Martin Akerman's guest appearances

Martin Akerman

The Alldus Podcast - AI in Action

MYRA Podcast

Chris Hutchins

John Collins

Kevin Johnson

Adam Wenchel

Kraft Heinz

Sean McDermott

Levi Strauss

Gina Bianchini

Jason King

Jenny Zhang

Martin Miller

Loren Brill

Gary Beasley

Rich Jones

Nitesh Banta

OwlTail

Today's guest is Martin Akerman, CTO and Co-Founder at Envisagenics in New York. Founded in 2014, it is their mission is to reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions through RNA splicing analytics and Artificial Intelligence. Over 30 million people in the US suffer from genetic diseases or cancer that could be caused by mutations affecting RNA splicing. 370 human diseases are known to be caused by splicing errors, and more remain to be discovered. Their breakthrough technology SpliceCore is a cloud-based platform that is experimentally validated to predict drug targets and biomarkers through splicing discovery from RNA-seq data using AI. This is used to identify splicing errors causative of diseases, identify the right drug-targets and develop RNA therapeutics through partnerships and collaborations with Biopharma. Their in-silico RNA therapeutics discovery platform replaces expensive drug-target selection and lead design with efficient computer simulations, decreasing time, cost and failure risk of drug development programs. In the show, Martin will chat about: Transitioning from academia into industry, The origins of their inspirational work at Envisagenics, The growth they have enjoyed since setting up the company, How to build a successful Data Science team, What excites him for the future at Envisagenics, Challenges they need to overcome to achieve their goals, &amp; How to transition into a career within Healthcare Data

Today's guest is Martin Akerman, CTO and Co-Founder at <a href="http://www.envisagenics.com/" rel="noopener nofollow" target="_blank">Envisagenics</a> in New York. Founded in 2014, it is their mission is to reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions through RNA splicing analytics and Artificial Intelligence. Over 30 million people in the US suffer from genetic diseases or cancer that could be caused by mutations affecting RNA splicing. 370 human diseases are known to be caused by splicing errors, and more remain to be discovered. Their breakthrough technology SpliceCore is a cloud-based platform that is experimentally validated to predict drug targets and biomarkers through splicing discovery from RNA-seq data using AI. This is used to identify splicing errors causative of diseases, identify the right drug-targets and develop RNA therapeutics through partnerships and collaborations with Biopharma. Their in-silico RNA therapeutics discovery platform replaces expensive drug-target selection and lead design with efficient computer simulations, decreasing time, cost and failure risk of drug development programs. In the show, Martin will chat about: Transitioning from academia into industry, The origins of their inspirational work at Envisagenics, The growth they have enjoyed since setting up the company, How to build a successful Data Science team, What excites him for the future at Envisagenics, Challenges they need to overcome to achieve their goals, &amp; How to transition into a career within Healthcare Data

E135 Martin Akerman, CTO and Co-Founder at Envisagenics

Martin Akerman is the co-founder and CEO of Envisagenics, a firm on a mission to reduce the complexity of big biomedical data into several smaller solutions and to boost the creation of new therapies. A data scientist trained in biology and computer science, with a Ph.D. and a postdoctoral, Martin is a global citizen with ancestral roots in Israel and Argentina. You can find show notes and more information by clicking here: http://bit.ly/2RkYWsh 

Martin Akerman is the co-founder and CEO of Envisagenics, a firm on a mission to reduce the complexity of big biomedical data into several smaller solutions and to boost the creation of new therapies. A data scientist trained in biology and computer science, with a Ph.D. and a postdoctoral, Martin is a global citizen with ancestral roots in Israel and Argentina. You can find show notes and more information by clicking here: <a href="http://bit.ly/2RkYWsh" rel="nofollow" target="_blank">http://bit.ly/2RkYWsh</a>

Ep #042: Curing Incurable Diseases and Redefining Success with Martin Akerman